Related Experiment Videos

PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells

Caiyan Zhao1, Wei Chen, Liu Yang

  • 1Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

Biochemical and Biophysical Research Communications
|October 3, 2006
PubMed

Insights

Peroxisome proliferator-activated receptor gamma (PPARgamma) agonists block liver fibrosis by inhibiting transforming growth factor-beta1 (TGFbeta1) signaling in hepatic stellate cells. This mechanism prevents extracellular matrix gene induction, offering a potential therapeutic strategy.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Hepatology

Background:

  • Liver fibrosis is a significant health concern with incompletely understood inhibitory mechanisms.
  • Peroxisome proliferator-activated receptor gamma (PPARgamma) agonists show anti-fibrotic potential.
  • Transforming growth factor-beta1 (TGFbeta1) signaling is implicated in liver fibrosis progression.

Purpose of the Study:

  • To elucidate the mechanism by which PPARgamma agonists inhibit liver fibrosis.
  • To investigate the role of PPARgamma agonists in regulating TGFbeta1 signaling in hepatic stellate cells (HSCs).

Main Methods:

  • Human HSCs were cultured to achieve a quiescent, adipocytic phenotype.
  • Cells were treated with TGFbeta1, a TGFbeta receptor-1 (TGFbetaR-1) kinase inhibitor (SB431542), or a PPARgamma agonist (GW7845).
  • Smad3 phosphorylation and expression of extracellular matrix (ECM) genes (PAI-1, collagen-1alphaI) were analyzed.

Main Results:

  • TGFbeta1 induced dose- and time-dependent increases in Smad3 phosphorylation and ECM gene expression.
  • PPARgamma agonist GW7845 inhibited these TGFbeta1-induced responses in a dose-dependent manner.
  • The PPARgamma agonist did not affect HSC proliferation or viability.

Conclusions:

  • PPARgamma agonists inhibit liver fibrosis by blocking TGFbeta1-TGFbetaR1 signaling in quiescent HSCs.
  • This inhibition abrogates Smad3-dependent induction of ECM genes, crucial for fibrogenesis.
  • PPARgamma agonists represent a promising therapeutic avenue for liver fibrosis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...